Scott M. Coiante

Insider Reports History

Identity 1 identity field
Location
Princeton, NJ
SEC source record 1 source field
Owner filing signature
/s/ Scott M. Coiante
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Scott M. Coiante

Form 4 holding SVP, Chief Financial Officer

Aprea Therapeutics, Inc.

Security class
Common Stock
Shares / value
145,065
Estimated value
$533,970
Report date
28 Jul 2022
Price
$3.68
Ownership
Direct
Form 4 holding SVP, Chief Financial Officer

LEXICON PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
320,473
Estimated value
$322,076
Report date
28 Feb 2026
Price
$0.6700
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

AGILE THERAPEUTICS INC

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
26 Aug 2024
Price
$1.52
Ownership
Direct
Form 4 holding SVP, Chief Financial Officer

Aprea Therapeutics, Inc.

Security class
Stock Option (right to Buy)
Shares / value
89,200
Estimated value
Report date
28 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Scott M. Coiante

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .